After the success of last year, SMi is delighted to announce the return of Lyophilization USA Conference to New Jersey, USA, taking place on November 15th - 16th 2018. This year's event will focus on providing attendees with the latest technological advancements in lyophilization.
16% of the top 100 pharmaceutical drugs and 35% of biologic drugs are lyophilized, and with more than 30% of the FDA-approved parenterals lyophilized and soon more than half of injectable drugs to require lyophilization, there鈥檚 a need for standardization and expansion of the lyophilization process in pharmaceuticals. Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are required for current and future products.
2018 Event Highlights:
- Discover novel techniques and advances within lyophilization
- Gain insight into the regulatory challenges and how to overcome them
- Discuss the current, unmet needs within lyophilization; and the action points needed to address them
- Explore the most recent analytical and other technologies
- Hear from experts on alternative freeze-drying methods e.g. spray drying and foam drying
Many pharmaceutical and biotech companies are expanding their lyophilization capacities to extend the lifespan of high-value products, such as vaccines, antibodies, proteins and blood plasma. As more biopharmaceutical drugs are being developed, the need for innovative lyophilization technologies is increasing.
In addition to exploring the future of lyophilization, the two-day conference will provide attendees with the opportunity to network with industry experts from whom they will gain insights into innovative technologies, discover new methods of scale-up and technology transfer, and explore alternative processes beyond lyophilization.
Register by:
29th June to save $300
28th September to save $100
To book your place and download the brochure, please visit: www.lyophilization-usa.com/evvnt
Speakers: Alex Langford, Senior Associate Scientist, Pfizer, Fabrice Schlegel, Senior Engineer, Amgen, Rui Fang, Senior Scientist, Merck, Sushma Kommareddy, Associate Director, Formulation Development, Takeda, Alina Alexeenko, Professor, Purdue University
16% of the top 100 pharmaceutical drugs and 35% of biologic drugs are lyophilized, and with more than 30% of the FDA-approved parenterals lyophilized and soon more than half of injectable drugs to require lyophilization, there鈥檚 a need for standardization and expansion of the lyophilization process in pharmaceuticals. Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are required for current and future products.
2018 Event Highlights:
- Discover novel techniques and advances within lyophilization
- Gain insight into the regulatory challenges and how to overcome them
- Discuss the current, unmet needs within lyophilization; and the action points needed to address them
- Explore the most recent analytical and other technologies
- Hear from experts on alternative freeze-drying methods e.g. spray drying and foam drying
Many pharmaceutical and biotech companies are expanding their lyophilization capacities to extend the lifespan of high-value products, such as vaccines, antibodies, proteins and blood plasma. As more biopharmaceutical drugs are being developed, the need for innovative lyophilization technologies is increasing.
In addition to exploring the future of lyophilization, the two-day conference will provide attendees with the opportunity to network with industry experts from whom they will gain insights into innovative technologies, discover new methods of scale-up and technology transfer, and explore alternative processes beyond lyophilization.
Register by:
29th June to save $300
28th September to save $100
To book your place and download the brochure, please visit: www.lyophilization-usa.com/evvnt
Speakers: Alex Langford, Senior Associate Scientist, Pfizer, Fabrice Schlegel, Senior Engineer, Amgen, Rui Fang, Senior Scientist, Merck, Sushma Kommareddy, Associate Director, Formulation Development, Takeda, Alina Alexeenko, Professor, Purdue University
